Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 2:59 PM
Ignite Modification Date:
2025-12-25 @ 1:23 PM
NCT ID:
NCT04076059
Group ID:
EG001
Title:
Placebo Plus ADT (Double Blind Phase)
Description:
Participants received enzalutamide-matching placebo capsules, orally once daily and continued ADT until radiographic disease progression was documented or until they started another investigational agent or new therapy for treatment of prostate cancer. Participants were to remain on study treatment until confirmed radiographic disease progression. ADT (either bilateral orchiectomy or LHRH agonist/antagonist) was maintained during study treatment.
Deaths Number Affected:
12
Deaths Number At Risk:
None
Serious Number Affected:
12
Serious Number At Risk:
59
Other Number Affected:
54
Other Number At Risk:
59
Study:
NCT04076059
Results Section:
NCT04076059
Adverse Events Module:
NCT04076059